Research Article
Development of a HPLC-MS/MS Method to Determine 11 Bioactive Compounds in Tongmai Yangxin Pill and Application to a Pharmacokinetic Study in Rats
Table 6
Pharmacokinetic parameters of 11 analytes after oral administration of TMYX extract (n=6).
| Compounds | Tmax1 (h) | Tmax2 (h) | Cmax1 (ng/mL) | Cmax2 (ng/mL) | t1/2 (h) | Ke (1/h) | (h·ng/mL) | (h·ng/mL) |
| rhein | 0.36±0.31 | | 46.3±15.6 | | 2.84±2.13 | 0.56±0.50 | 145.0±52.6 | 152.1±61.3 | emodin | 0.32±0.14 | | 88.0±37.5 | | 4.21±2.63 | 0.39±0.28 | 475.5±121.0 | 561.3±192.3 | stilbene glycoside | 0.50±0.31 | | 99.1±27.1 | | 1.99±1.31 | 0.45±0.24 | 283.8±189.1 | 297.5±185.3 | liquiritin | 0.50±0.46 | | 199.9±120.2 | | 2.16±1.44 | 0.77±0.54 | 637.2±220.2 | 651.1±219.5 | ononin | 0.46±0.10 | | 14.4±6.8 | | 2.85±1.40 | 0.37±0.25 | 58.2±20.2 | 69.4±28.5 | verbascoside | 0.37±0.18 | | 23.4±8.7 | | 1.53±0.67 | 0.56±0.31 | 51.4±29.8 | 61.0±29.8 | gallic acid | 0.75±0.67 | | 56.9±42.8 | | 3.01±1.35 | 0.27±0.12 | 214.7±136.7 | 238.4±172.8 | schisandrin | 1.00±0.92 | | 92.6±53.0 | | 2.73±1.54 | 0.34±0.19 | 410.8±238.9 | 473.4±321.2 | liquiritigenin | 0.20±0.07 | 7.20±3.35 | 37.8±24.1 | 21.0±15.3 | 12.70±7.04 | 0.50±0.34 | 314.8±129.8 | 332.6±142.1 | glycyrrhizic acid | 2.13±1.44 | 17.67±10.31 | 351.7±347.4 | 476.1±146.0 | 18.19±9.61 | 0.05±0.03 | 12743.5±5058.2 | 17327.3±10967.3 | isoliquiritigenin | 0.28±0.11 | 7.00±2.45 | 41.6±24.2 | 24.9±13.5 | 13.46±8.33 | 0.07±0.04 | 410.0±130.7 | 436.2±154.1 |
|
|